In conclusion, this rather rare case highlights the role of the KIT D816V mutation in combination with NRAS and TP53 mutations in driving the malignancies of ovarian GCT and MCL, as well as the challenges it poses for diagnosis and treatment. The gene discussed is NRAS; the disease is mantle cell lymphoma.